Free Trial

Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Crosses Below 200 Day Moving Average - Should You Sell?

Northwest Biotherapeutics logo with Medical background

Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO - Get Free Report)'s share price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.30 and traded as low as $0.27. Northwest Biotherapeutics shares last traded at $0.27, with a volume of 2,896,227 shares.

Northwest Biotherapeutics Price Performance

The business has a 50 day moving average price of $0.28 and a 200 day moving average price of $0.30. The stock has a market capitalization of $387.19 million, a PE ratio of -3.60 and a beta of -0.51.

Northwest Biotherapeutics (OTCMKTS:NWBO - Get Free Report) last issued its earnings results on Tuesday, November 12th. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $0.36 million for the quarter.

Northwest Biotherapeutics Company Profile

(Get Free Report)

Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.

Further Reading

Should You Invest $1,000 in Northwest Biotherapeutics Right Now?

Before you consider Northwest Biotherapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Northwest Biotherapeutics wasn't on the list.

While Northwest Biotherapeutics currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Explosive Growth: Buy Now or Wait for a Dip?
5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines